glp 1 agonists with cardiovascular benefit Frontiers The Many Cardiovascular Benefits of

Trends Biochem Sci

GLP-1 medications require a prescription and should be used only under the guidance of a licensed healthcare professional

The stimulant effects of phentermine (increased heart rate, elevated blood pressure) combined with the cardiovascular changes produced by GLP-1 medications created a physiological profile that researchers flagged for further investigation

Dual GLP-1/GIP agonists represent a significant new strategy for cardiovascular risk reduction, with ongoing research exploring triple GLP-1/GIP/glucagon agonists for even greater efficacy [68]

In summary, GLP-1 RAs, through weight loss and the reduction of pro-inflammatory cytokines [31, 33], could provide a complementary approach to standard therapies for HS, especially in patients with obesity [36]

In the psoriatic arthritis market, SOTYKTU is expected to compete primarily with oral therapies such as Pfizers XELJANZ, AbbVies RINVOQ, and Amgens OTEZLA, while also facing potential competition from emerging TYK2 inhibitors, including Zasocitinib (TAK-279) from Takeda